-
1
-
-
0036718539
-
Molecular basis of the VHL hereditary cancer syndrome
-
Kaelin, W.G. 2002. Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer. 2: 673-682.
-
(2002)
Nat Rev Cancer.
, vol.2
, pp. 673-682
-
-
Kaelin, W.G.1
-
2
-
-
43649093915
-
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway
-
Kaelin, W.G. Jr. & P.J. Ratcliffe 2008. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell. 30: 393-402.
-
(2008)
Mol. Cell.
, vol.30
, pp. 393-402
-
-
Kaelin Jr., W.G.1
Ratcliffe, P.J.2
-
3
-
-
0043234538
-
Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor
-
Hirsila, M. et al 2003. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem. 278: 30772-30780.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 30772-30780
-
-
Hirsila, M.1
-
4
-
-
0037124173
-
The use of dioxygen by HIF prolyl hydroxylase (PHD1)
-
McNeill, L.A. et al 2002. The use of dioxygen by HIF prolyl hydroxylase (PHD1). Bioorg. Med. Chem. Lett. 12: 1547-1550.
-
(2002)
Bioorg. Med. Chem. Lett.
, vol.12
, pp. 1547-1550
-
-
McNeill, L.A.1
-
5
-
-
0041465022
-
HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia
-
Berra, E. et al 2003. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. Embo. J. 22: 4082-4090.
-
(2003)
Embo. J.
, vol.22
, pp. 4082-4090
-
-
Berra, E.1
-
6
-
-
4644318828
-
Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor
-
Appelhoff, R.J. et al 2004. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 279: 38458-38465.
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 38458-38465
-
-
Appelhoff, R.J.1
-
7
-
-
70350456693
-
A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo
-
Minamishima, Y.A. et al 2009. A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo. Mol. Cell. Biol. 29: 5729-5741.
-
(2009)
Mol. Cell. Biol.
, vol.29
, pp. 5729-5741
-
-
Minamishima, Y.A.1
-
8
-
-
42449163874
-
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
-
Minamishima, Y.A. et al 2008. Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood 111: 3236-3244.
-
(2008)
Blood
, vol.111
, pp. 3236-3244
-
-
Minamishima, Y.A.1
-
9
-
-
40949090791
-
Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins
-
Takeda, K. et al 2008. Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. Blood 111: 3229-3235.
-
(2008)
Blood
, vol.111
, pp. 3229-3235
-
-
Takeda, K.1
-
10
-
-
31444436640
-
A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis
-
Percy, M.J. et al 2006. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc. Natl. Acad. Sci. USA 103: 654-659.
-
(2006)
Proc. Natl. Acad. Sci. USA
, vol.103
, pp. 654-659
-
-
Percy, M.J.1
-
11
-
-
34548848799
-
A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove
-
Percy, M.J. et al 2007. A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove. Blood 110: 2193-2196.
-
(2007)
Blood
, vol.110
, pp. 2193-2196
-
-
Percy, M.J.1
-
12
-
-
34347378904
-
Prevalence, etiology, and consequences of anemia and clinical and economic benefits of anemia correction in patients with chronic kidney disease: an overview
-
S3-7; quiz S23-25
-
Dowling, T.C. 2007. Prevalence, etiology, and consequences of anemia and clinical and economic benefits of anemia correction in patients with chronic kidney disease: an overview. Am. J. Health Syst. Pharm. 64: S3-7; quiz S23-25.
-
(2007)
Am. J. Health Syst. Pharm.
, vol.64
-
-
Dowling, T.C.1
-
13
-
-
77954837178
-
Reactivation of hepatic EPO synthesis in mice after PHD loss
-
Minamishima, Y.A. & W.G. Kaelin Jr. Reactivation of hepatic EPO synthesis in mice after PHD loss. Science 329: 407.
-
Science
, vol.329
, pp. 407
-
-
Minamishima, Y.A.1
Kaelin Jr., W.G.2
-
14
-
-
30444445382
-
Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production
-
Safran, M. et al 2006. Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. Proc. Natl. Acad. Sci. USA 103: 105-110.
-
(2006)
Proc. Natl. Acad. Sci. USA
, vol.103
, pp. 105-110
-
-
Safran, M.1
-
16
-
-
39749132878
-
The von hippel-lindau tumor suppressor protein: an update
-
Kaelin, W.G., Jr. 2007. The von hippel-lindau tumor suppressor protein: an update. Methods Enzymol. 435: 371-383.
-
(2007)
Methods Enzymol.
, vol.435
, pp. 371-383
-
-
Kaelin Jr., W.G.1
-
17
-
-
34047156190
-
HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity
-
Gordan, J.D. et al 2007. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell. 11: 335-347.
-
(2007)
Cancer Cell.
, vol.11
, pp. 335-347
-
-
Gordan, J.D.1
-
18
-
-
56849096837
-
HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma
-
Gordan, J.D. et al 2008. HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell. 14: 435-446.
-
(2008)
Cancer Cell.
, vol.14
, pp. 435-446
-
-
Gordan, J.D.1
-
19
-
-
0033587146
-
The von Hippel-Lindau gene product is necessary for oxgyen-dependent proteolysis of hypoxia-inducible factor a subunits
-
Maxwell, P. et al 1999. The von Hippel-Lindau gene product is necessary for oxgyen-dependent proteolysis of hypoxia-inducible factor a subunits. Nature 399: 271-275.
-
(1999)
Nature
, vol.399
, pp. 271-275
-
-
Maxwell, P.1
-
20
-
-
0036528246
-
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
-
Kondo, K. et al 2002. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell. 1: 237-246.
-
(2002)
Cancer Cell.
, vol.1
, pp. 237-246
-
-
Kondo, K.1
-
21
-
-
0036527785
-
The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma
-
Maranchie, J.K. et al 2002. The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell. 1: 247-255.
-
(2002)
Cancer Cell.
, vol.1
, pp. 247-255
-
-
Maranchie, J.K.1
-
22
-
-
85027722628
-
Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth
-
Kondo, K. et al 2003. Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth. PLos Biol. 1: 439-444.
-
(2003)
PLos Biol
, vol.1
, pp. 439-444
-
-
Kondo, K.1
-
23
-
-
1342280515
-
Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors
-
Zimmer, M. et al 2004. Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors. Mol. Cancer Res. 2: 89-95.
-
(2004)
Mol. Cancer Res.
, vol.2
, pp. 89-95
-
-
Zimmer, M.1
-
24
-
-
33749344471
-
Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo
-
Kim, W.Y. et al 2006. Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo. Embo J. 25: 4650-4662.
-
(2006)
Embo J.
, vol.25
, pp. 4650-4662
-
-
Kim, W.Y.1
-
25
-
-
34147124264
-
Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo
-
Rankin, E.B. et al 2007. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J. Clin. Invest. 117: 1068-1077.
-
(2007)
J. Clin. Invest.
, vol.117
, pp. 1068-1077
-
-
Rankin, E.B.1
-
26
-
-
51649090078
-
Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice
-
Rankin, E.B. et al 2008. Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice. Oncogene 27: 5354-5358.
-
(2008)
Oncogene
, vol.27
, pp. 5354-5358
-
-
Rankin, E.B.1
-
27
-
-
68949098346
-
HIF-2 regulates hepatic lipid metabolism
-
Rankin, E.B. et al 2009. HIF-2 regulates hepatic lipid metabolism. Mol. Cel. Biol. 29: 4527-4538.
-
(2009)
Mol. Cel. Biol.
, vol.29
, pp. 4527-4538
-
-
Rankin, E.B.1
-
28
-
-
17044452288
-
HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron
-
Mandriota, S.J. et al 2002. HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron. Cancer Cell. 1: 459-468.
-
(2002)
Cancer Cell.
, vol.1
, pp. 459-468
-
-
Mandriota, S.J.1
-
29
-
-
37349080670
-
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
-
Escudier, B. et al 2007. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. Lancet 370: 2103-2111.
-
(2007)
Lancet
, vol.370
, pp. 2103-2111
-
-
Escudier, B.1
-
30
-
-
33846148701
-
Sorafenib in advanced clear-cell renal-cell carcinoma
-
Escudier, B. et al 2007. Sorafenib in advanced clear-cell renal-cell carcinoma. N. Engl. J. Med. 356: 125-134.
-
(2007)
N. Engl. J. Med.
, vol.356
, pp. 125-134
-
-
Escudier, B.1
-
31
-
-
33846181370
-
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
-
Motzer, R.J. et al 2007. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N. Engl. J. Med. 356: 115-124.
-
(2007)
N. Engl. J. Med.
, vol.356
, pp. 115-124
-
-
Motzer, R.J.1
-
32
-
-
77949890945
-
Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial
-
Sternberg, C.N. et al Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial. J. Clin. Oncol. 28: 1061-1068.
-
J. Clin. Oncol.
, vol.28
, pp. 1061-1068
-
-
Sternberg, C.N.1
-
33
-
-
84859920853
-
-
A phase 3, randomized, 3-arm study of temsirolimus (TEMSR) or interferon-alpha (IFN) or the combination of TEMSR + IFN in the treatment of first-line, poor-risk patients with advanced renal cell carcinoma (adv RCC). In JCO, 2006 ASCO Annual Meetings Proceedings Part I. 24: LBA4.
-
Hudes, G. et al 2006. A phase 3, randomized, 3-arm study of temsirolimus (TEMSR) or interferon-alpha (IFN) or the combination of TEMSR + IFN in the treatment of first-line, poor-risk patients with advanced renal cell carcinoma (adv RCC). In JCO, 2006 ASCO Annual Meetings Proceedings Part I. 24: LBA4.
-
(2006)
-
-
Hudes, G.1
-
34
-
-
48649107474
-
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
-
Motzer, R.J. et al 2008. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet 372: 449-456.
-
(2008)
Lancet
, vol.372
, pp. 449-456
-
-
Motzer, R.J.1
-
35
-
-
34347220473
-
Defining the role of mTOR in cancer
-
Guertin, D.A. & D.M. Sabatini 2007. Defining the role of mTOR in cancer. Cancer Cell. 12: 9-22.
-
(2007)
Cancer Cell.
, vol.12
, pp. 9-22
-
-
Guertin, D.A.1
Sabatini, D.M.2
-
36
-
-
58049216350
-
Differential dependence of HIF1alpha and HIF2alpha on mTORC1 and mTORC2
-
Toschi, A. et al 2008. Differential dependence of HIF1alpha and HIF2alpha on mTORC1 and mTORC2. J. Biol. Chem. 283: 34495-34499.
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 34495-34499
-
-
Toschi, A.1
-
37
-
-
75149188170
-
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
-
Dalgliesh, G.L. et al 2010. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463: 360-363.
-
(2010)
Nature
, vol.463
, pp. 360-363
-
-
Dalgliesh, G.L.1
-
38
-
-
66349100709
-
Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney
-
Beroukhim, R. et al 2009. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res. 69: 4674-4681.
-
(2009)
Cancer Res.
, vol.69
, pp. 4674-4681
-
-
Beroukhim, R.1
-
39
-
-
70349880529
-
Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays
-
Chen, M. et al 2009. Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays. Int. J. Cancer 125: 2342-2348.
-
(2009)
Int. J. Cancer
, vol.125
, pp. 2342-2348
-
-
Chen, M.1
-
40
-
-
36749049879
-
High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma
-
Yoshimoto, T. et al 2007. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma. J. Pathol. 213: 392-401.
-
(2007)
J. Pathol.
, vol.213
, pp. 392-401
-
-
Yoshimoto, T.1
-
41
-
-
39749116278
-
Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile
-
Cifola, I. et al 2008. Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile. Mol. Cancer 7: 6.
-
(2008)
Mol. Cancer
, vol.7
, pp. 6
-
-
Cifola, I.1
-
42
-
-
55949101858
-
Kinase requirements in human cells: III. Altered kinase requirements in VHL-/- cancer cells detected in a pilot synthetic lethal screen
-
Bommi-Reddy, A. et al 2008. Kinase requirements in human cells: III. Altered kinase requirements in VHL-/- cancer cells detected in a pilot synthetic lethal screen. Proc. Natl Acad. Sci. USA 105: 16484-16489.
-
(2008)
Proc. Natl Acad. Sci. USA
, vol.105
, pp. 16484-16489
-
-
Bommi-Reddy, A.1
-
43
-
-
45849147350
-
A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy
-
Turcotte, S. et al 2008. A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell. 14: 90-102.
-
(2008)
Cancer Cell.
, vol.14
, pp. 90-102
-
-
Turcotte, S.1
-
44
-
-
69249247037
-
SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling
-
Kaelin, W.G., Jr. 2009. SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling. Cancer Cell. 16: 180-182.
-
(2009)
Cancer Cell.
, vol.16
, pp. 180-182
-
-
Kaelin Jr., W.G.1
-
45
-
-
33947520506
-
Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF
-
Koivunen, P. et al 2007. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J. Biol. Chem. 282: 4524-4532.
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 4524-4532
-
-
Koivunen, P.1
-
46
-
-
26444570010
-
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations
-
Pollard, P.J. et al 2005. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet. 14: 2231-2239.
-
(2005)
Hum. Mol. Genet.
, vol.14
, pp. 2231-2239
-
-
Pollard, P.J.1
-
47
-
-
19944433653
-
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase
-
Selak, M.A. et al 2005. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell. 7: 77-85.
-
(2005)
Cancer Cell.
, vol.7
, pp. 77-85
-
-
Selak, M.A.1
-
48
-
-
34047167041
-
Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway
-
Pollard, P.J. et al 2007. Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway. Cancer Cell. 11: 311-319.
-
(2007)
Cancer Cell.
, vol.11
, pp. 311-319
-
-
Pollard, P.J.1
-
49
-
-
77955594623
-
A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas
-
Dahia, P.L. et al 2005. A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet 1: 72-80.
-
(2005)
PLoS Genet
, vol.1
, pp. 72-80
-
-
Dahia, P.L.1
-
50
-
-
56749156414
-
Analysis of the IDH1 codon 132 mutation in brain tumors
-
Balss, J. et al 2008. Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol. 116: 597-602.
-
(2008)
Acta Neuropathol.
, vol.116
, pp. 597-602
-
-
Balss, J.1
-
51
-
-
52949127312
-
An integrated genomic analysis of human glioblastoma multiforme
-
Parsons, D.W. et al 2008. An integrated genomic analysis of human glioblastoma multiforme. Science 321: 1807-1812.
-
(2008)
Science
, vol.321
, pp. 1807-1812
-
-
Parsons, D.W.1
-
52
-
-
65349150503
-
IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas
-
Watanabe, T. et al 2009. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am. J. Pathol. 174: 1149-1153.
-
(2009)
Am. J. Pathol.
, vol.174
, pp. 1149-1153
-
-
Watanabe, T.1
-
53
-
-
60849115270
-
IDH1 and IDH2 mutations in gliomas
-
Yan, H. et al 2009. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360: 765-773.
-
(2009)
N. Engl. J. Med.
, vol.360
, pp. 765-773
-
-
Yan, H.1
-
54
-
-
77952536841
-
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
-
Marcucci, G. et al IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. J. Clin. Oncol. 28: 2348-2355.
-
J. Clin. Oncol.
, vol.28
, pp. 2348-2355
-
-
Marcucci, G.1
-
55
-
-
77649305610
-
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate
-
Ward, P.S. et al 2010. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell. 17: 225-234.
-
(2010)
Cancer Cell.
, vol.17
, pp. 225-234
-
-
Ward, P.S.1
-
56
-
-
72049125350
-
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
-
Dang, L. et al 2009. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462: 739-744.
-
(2009)
Nature
, vol.462
, pp. 739-744
-
-
Dang, L.1
-
57
-
-
77149134353
-
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations
-
Gross, S. et al 2010. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J. Exp. Med. 207: 339-344.
-
(2010)
J. Exp. Med.
, vol.207
, pp. 339-344
-
-
Gross, S.1
-
58
-
-
0035221419
-
The DNA-repair protein AlkB, EGL-9, and leprecan define new families of 2-oxoglutarate- and iron-dependent dioxygenases
-
Aravind, L. & E.V. Koonin 2001. The DNA-repair protein AlkB, EGL-9, and leprecan define new families of 2-oxoglutarate- and iron-dependent dioxygenases. Genome Bio. 2: research0007.1-0007.8.
-
(2001)
Genome Bio.
, vol.2
-
-
Aravind, L.1
Koonin, E.V.2
-
59
-
-
59649117924
-
Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization
-
Mazzone, M. et al 2009. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136: 839-851.
-
(2009)
Cell
, vol.136
, pp. 839-851
-
-
Mazzone, M.1
-
60
-
-
0037165244
-
Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression)
-
Seth, P. et al 2002. Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression). Oncogene 21: 836-843.
-
(2002)
Oncogene
, vol.21
, pp. 836-843
-
-
Seth, P.1
-
61
-
-
70350507985
-
Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase
-
Zhang, Q. et al 2009. Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase. Cancer Cell. 16: 413-424.
-
(2009)
Cancer Cell.
, vol.16
, pp. 413-424
-
-
Zhang, Q.1
-
62
-
-
0029111934
-
Cyclin D1 provides a link between development and oncogenesis in the retina and breast
-
Sicinski, P. et al 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82: 621-630.
-
(1995)
Cell
, vol.82
, pp. 621-630
-
-
Sicinski, P.1
-
63
-
-
23644436667
-
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer
-
Lee, S. et al 2005. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell. 8: 155-167.
-
(2005)
Cancer Cell.
, vol.8
, pp. 155-167
-
-
Lee, S.1
-
64
-
-
0033066605
-
Expression of the SM-20 gene promotes death in nerve growth factor-dependent sympathetic neurons
-
Lipscomb, E. et al 1999. Expression of the SM-20 gene promotes death in nerve growth factor-dependent sympathetic neurons. J. Neurochem. 73: 429-432.
-
(1999)
J. Neurochem.
, vol.73
, pp. 429-432
-
-
Lipscomb, E.1
-
65
-
-
0035895928
-
SM-20 is a novel mitochondrial protein that causes caspase-dependent cell death in nerve growth factor-dependent neurons
-
Lipscomb, E. P. Sarmiere & R. Freeman 2001. SM-20 is a novel mitochondrial protein that causes caspase-dependent cell death in nerve growth factor-dependent neurons. J. Biol. Chem. 276: 11775-11782.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 11775-11782
-
-
Lipscomb, E.1
Sarmiere, P.2
Freeman, R.3
-
66
-
-
43249108443
-
Abnormal sympathoadrenal development and systemic hypotension in PHD3-/- mice
-
Bishop, T. et al 2008. Abnormal sympathoadrenal development and systemic hypotension in PHD3-/- mice. Mol. Cell. Biol. 28: 3386-3400.
-
(2008)
Mol. Cell. Biol.
, vol.28
, pp. 3386-3400
-
-
Bishop, T.1
-
67
-
-
41649116940
-
The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
-
Schlisio, S. et al 2008. The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor. Genes Dev. 22: 884-893.
-
(2008)
Genes Dev.
, vol.22
, pp. 884-893
-
-
Schlisio, S.1
-
68
-
-
48249154559
-
Prolyl hydroxylase PHD3 activates oxygen-dependent protein aggregation
-
Rantanen, K. et al 2008. Prolyl hydroxylase PHD3 activates oxygen-dependent protein aggregation. Mol. Biol. Cell. 19: 2231-2240.
-
(2008)
Mol. Biol. Cell.
, vol.19
, pp. 2231-2240
-
-
Rantanen, K.1
-
69
-
-
53749107898
-
A germline mutation of the KIF1B beta gene on 1p36 in a family with neural and nonneural tumors
-
Yeh, I.T. et al 2008. A germline mutation of the KIF1B beta gene on 1p36 in a family with neural and nonneural tumors. Hum Genet. 124: 279-285.
-
(2008)
Hum Genet.
, vol.124
, pp. 279-285
-
-
Yeh, I.T.1
-
70
-
-
54049148638
-
KIF1Bbeta functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death
-
Munirajan, A.K. et al 2008. KIF1Bbeta functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death. J. Biol. Chem. 283: 24426-24434.
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 24426-24434
-
-
Munirajan, A.K.1
-
71
-
-
34247553146
-
Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells
-
MacKenzie, E.D. et al 2007. Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol. Cell Biol. 27: 3282-3289.
-
(2007)
Mol. Cell Biol.
, vol.27
, pp. 3282-3289
-
-
MacKenzie, E.D.1
-
72
-
-
70449624093
-
Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death
-
Tennant, D.A. et al 2009. Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death. Oncogene 28: 4009-4021.
-
(2009)
Oncogene
, vol.28
, pp. 4009-4021
-
-
Tennant, D.A.1
-
73
-
-
33747455678
-
JmjC-domain-containing proteins and histone demethylation
-
Klose, R.J. E.M. Kallin & Y. Zhang 2006. JmjC-domain-containing proteins and histone demethylation. Nat. Rev. Genet. 7: 715-727.
-
(2006)
Nat. Rev. Genet.
, vol.7
, pp. 715-727
-
-
Klose, R.J.1
Kallin, E.M.2
Zhang, Y.3
-
74
-
-
33748291758
-
Roles of jumonji and jumonji family genes in chromatin regulation and development
-
Takeuchi, T. et al 2006. Roles of jumonji and jumonji family genes in chromatin regulation and development. Dev Dyn. 235: 2449-2459.
-
(2006)
Dev Dyn.
, vol.235
, pp. 2449-2459
-
-
Takeuchi, T.1
-
75
-
-
33746332412
-
The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3
-
Cloos, P.A. et al 2006. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature 442: 307-311.
-
(2006)
Nature
, vol.442
, pp. 307-311
-
-
Cloos, P.A.1
-
76
-
-
63449115501
-
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma
-
Northcott, P.A. et al 2009. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat. Genet. 41: 465-472.
-
(2009)
Nat. Genet.
, vol.41
, pp. 465-472
-
-
Northcott, P.A.1
-
77
-
-
67349203626
-
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
-
van Haaften, G. et al 2009. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat. Genet. 41: 521-523.
-
(2009)
Nat. Genet.
, vol.41
, pp. 521-523
-
-
van Haaften, G.1
-
78
-
-
67349266612
-
Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger
-
Wang, G.G. et al 2009. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature 459: 847-851.
-
(2009)
Nature
, vol.459
, pp. 847-851
-
-
Wang, G.G.1
-
79
-
-
0037145309
-
PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer/testis antigen?
-
Barrett, A. et al 2002. PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues: a new cancer/testis antigen? Int. J. Cancer 101: 581-588.
-
(2002)
Int. J. Cancer
, vol.101
, pp. 581-588
-
-
Barrett, A.1
-
80
-
-
33645826250
-
Identification of NUP98 abnormalities in acute leukemia: JARID1A (12p13) as a new partner gene
-
van Zutven, L.J. et al 2006. Identification of NUP98 abnormalities in acute leukemia: JARID1A (12p13) as a new partner gene. Genes Chromosomes Cancer 45: 437-446.
-
(2006)
Genes Chromosomes Cancer
, vol.45
, pp. 437-446
-
-
van Zutven, L.J.1
-
81
-
-
0025808021
-
Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product
-
Defeo-Jones, D. et al 1991. Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature 352: 251-254.
-
(1991)
Nature
, vol.352
, pp. 251-254
-
-
Defeo-Jones, D.1
-
82
-
-
0031930466
-
Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth
-
Sellers, W.R. et al 1998. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev. 12: 95-106.
-
(1998)
Genes Dev.
, vol.12
, pp. 95-106
-
-
Sellers, W.R.1
-
83
-
-
20444429760
-
Binding of pRB to the PHD protein RBP2 promotes cellular differentiation
-
Benevolenskaya, E.V. et al 2005. Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol. Cell 18: 623-635.
-
(2005)
Mol. Cell
, vol.18
, pp. 623-635
-
-
Benevolenskaya, E.V.1
-
84
-
-
77950809059
-
A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations
-
Sharma, S.V. et al 2010. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141: 69-80.
-
(2010)
Cell
, vol.141
, pp. 69-80
-
-
Sharma, S.V.1
-
85
-
-
33947244845
-
PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation
-
Yamane, K. et al 2007. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol. Cell 25: 801-812.
-
(2007)
Mol. Cell
, vol.25
, pp. 801-812
-
-
Yamane, K.1
-
86
-
-
77952502408
-
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth
-
Roesch, A. et al 2010. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141: 583-594.
-
(2010)
Cell
, vol.141
, pp. 583-594
-
-
Roesch, A.1
|